1. Home
  2. AVY vs MDGL Comparison

AVY vs MDGL Comparison

Compare AVY & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avery Dennison Corporation

AVY

Avery Dennison Corporation

N/A

Current Price

$187.99

Market Cap

12.8B

ML Signal

N/A

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

N/A

Current Price

$427.76

Market Cap

11.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVY
MDGL
Founded
1935
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.8B
11.5B
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
AVY
MDGL
Price
$187.99
$427.76
Analyst Decision
Buy
Strong Buy
Analyst Count
11
19
Target Price
$203.30
★ $688.78
AVG Volume (30 Days)
★ 582.2K
526.8K
Earning Date
10-29-2026
11-03-2026
Dividend Yield
★ 2.14%
N/A
EPS Growth
★ 0.69
N/A
EPS
★ 7.09
N/A
Revenue
N/A
★ $180,133,000.00
Revenue This Year
$5.95
$65.40
Revenue Next Year
$2.76
$37.87
P/E Ratio
$26.41
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$152.42
$353.54
52 Week High
$199.54
$615.00

Technical Indicators

Market Signals
Indicator
AVY
MDGL
Relative Strength Index (RSI) 60.88 40.94
Support Level $165.09 $416.21
Resistance Level $197.47 $553.95
Average True Range (ATR) 4.45 24.52
MACD -0.08 3.61
Stochastic Oscillator 57.76 54.17

Price Performance

Historical Comparison
AVY
MDGL

About AVY Avery Dennison Corporation

Avery Dennison Corp provides materials science and digital identification solutions, offering labeling and functional materials, RFID inlays and tags, software connecting physical and digital, and products that enhance packaging and customer experience. Serving industries including retail, apparel, e-commerce, logistics, food, pharmaceuticals, and automotive it operates through two reportable segments: Materials Group, which manufactures and sells pressure-sensitive label materials, graphics, reflective products, performance tapes, and other adhesive solutions, and earns the majority of revenue; and Solutions Group, which provides brand and price tickets, tags, labels with RFID inlays, and related services, supplies, and equipment.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: